These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2422901)

  • 1. Acute hemodynamic effects of an antitumoral agent: elliptinium. Involvement of histamine release.
    Eschalier A; Lavarenne J; Burtin C; Tounissou P
    Agents Actions; 1986 Mar; 17(5-6):441-8. PubMed ID: 2422901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular effects of elliptinium. The mechanism of action].
    Eschalier A; Lavarenne J; Dureng G; Rodriguez M; Tounissou P
    J Pharmacol; 1984; 15(3):301-8. PubMed ID: 6492819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and vascular effects of elliptinium in guinea pigs. Involvement of a histaminergic mechanism.
    Eschalier A; Lavarenne J; Renoux M; Tounissou P
    Agents Actions; 1985 Jul; 16(5):302-5. PubMed ID: 4050612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of histamine release induced by acute administration of antitumor agents in dogs.
    Eschalier A; Lavarenne J; Burtin C; Renoux M; Chapuy E; Rodriguez M
    Cancer Chemother Pharmacol; 1988; 21(3):246-50. PubMed ID: 2452032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular activity of 9-hydroxy-ellipticine.
    Chanh PH; Xuong ND; Le Pecq JB; Paoletti C
    Pharmacology; 1976; 14(6):490-8. PubMed ID: 1019225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic cardiovascular effects of doxorubicin in the dog: the cardiovascular pharmacology of drug-induced histamine release.
    Bristow MR; Sageman WS; Scott RH; Billingham ME; Bowden RE; Kernoff RS; Snidow GH; Daniels JR
    J Cardiovasc Pharmacol; 1980; 2(5):487-515. PubMed ID: 6157945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular effect and toxicity of hydroxy-9-ellipticine in dogs].
    Pham-Huu-Chanh ; Sorbara R; Dat-Xuong ND; Le Pecq JB; Paoletti C
    C R Acad Hebd Seances Acad Sci D; 1974 Sep; 279(12):1039-42. PubMed ID: 4219306
    [No Abstract]   [Full Text] [Related]  

  • 8. Histamine-releasing properties of hydroxy-9-methyl-2-ellipticinium acetate.
    Eschalier A; Advenier C; Lebel B; Burtin C; Lavarenne J
    Cancer Chemother Pharmacol; 1981; 5(4):233-6. PubMed ID: 6167376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between the cardiovascular actions of urocortin 1 and urocortin 2 (stresscopin-related peptide) in conscious rats.
    Gardiner SM; March JE; Kemp PA; Bennett T
    J Pharmacol Exp Ther; 2007 Apr; 321(1):221-6. PubMed ID: 17237259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of burimamide, an H-2 receptor antagonist, upon the general and coronary haemodynamics of intact dogs and upon histamine release by Tween 20.
    Maxwell GM; Rencis V
    Aust J Exp Biol Med Sci; 1974 Oct; 52(5):825-32. PubMed ID: 4141247
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
    Drieu la Rochelle CD; Grosset A; O'Connor SE
    Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
    Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
    Côté P; Polumbo RA; Harrison DC
    Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular responses to parathyroid hormone.
    Crass MF; Moore PL; Strickland ML; Pang PK; Citak MS
    Am J Physiol; 1985 Aug; 249(2 Pt 1):E187-94. PubMed ID: 4025539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular actions of three harmala alkaloids: harmine, harmaline, and harmalol.
    Aarons DH; Rossi GV; Orzechowski RF
    J Pharm Sci; 1977 Sep; 66(9):1244-8. PubMed ID: 903860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nitroglycerin and propranolol on the distribution of transmural myocardial blood flow during ischemia in the absence of hemodynamic changes in the unanesthetized dog.
    Swain JL; Parker JP; McHale PA; Greenfield JC
    J Clin Invest; 1979 May; 63(5):947-53. PubMed ID: 109467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction between histamine and ouabain on ventricular fibrillation threshold.
    Trzeciakowski JP
    Br J Pharmacol; 1985 May; 85(1):21-7. PubMed ID: 2862939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of amitriptyline in anaesthetized dogs.
    Dhumma-Upakorn P; Cobbin LB
    Clin Exp Pharmacol Physiol; 1977; 4(2):121-9. PubMed ID: 884904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liberation of endogenous compounds by tolazoline.
    Hughes MJ; O'Brien LJ
    Agents Actions; 1977 Jul; 7(2):225-30. PubMed ID: 70988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.